Search clinical trials for: Device: Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT)

Total 132 results

Alpha Tau Medical LTD.

Terminated

Alpha Radiation Emitters Device for the Treatment of Newly Diagnosed Breast Carcinoma Patients With Distant Metastases

Metastatic Breast Cancer | Breast Carcinoma | Invasive Breast Cancer | Distant Metastases.Pathology

Russian Federation
Alpha Tau Medical LTD.

Recruiting

Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal and Superficial Soft Tissue Neoplasia (DaRT)

Skin Cancer | Mucosal Neoplasm of Oral Cavity | Soft Tissue Neoplasm

Italy
Alpha Tau Medical LTD.

Recruiting

Retreatment With Intratumoral Diffusing Alpha Radiation Emitters

Skin Cancer | Mucosal Neoplasm of Oral Cavity | Soft Tissue Neoplasm

Israel
Alpha Tau Medical LTD.

Recruiting

Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia

Skin Cancer | Mucosal Neoplasm of Oral Cavity | Soft Tissue Neoplasm

Israel
Alpha Tau Medical LTD.

Completed

Alpha Radiation Emitters Device for the Treatment of Squamous Cell Carcinoma (DaRT)

Skin Squamous Cell Carcinoma

Italy
Alpha Tau Medical LTD.

Active, not recruiting

Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia (DaRT)

Skin Cancer | Mucosal Neoplasm of Oral Cavity | Soft Tissue Neoplasm

Israel
Alpha Tau Medical LTD.
European Organisation for Research and Treatment of Cancer - EORTC

Not yet recruiting

Neoadjuvant DaRT for Locally Advanced Oral Cavity SCC

Head and Neck Squamous Cell Carcinoma | Squamous Cell Carcinoma

Israel
Alpha Tau Medical LTD.

Recruiting

Alpha Radiation Emitters Device for the Treatment of Recurrent Lung Cancer

Lung Cancer | Recurrent Lung Cancer

Israel
Alpha Tau Medical LTD.

Recruiting

Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia.

Skin Cancer | Mucosal Neoplasm of Oral Cavity | Soft Tissue Neoplasm

Israel
Alpha Tau Medical LTD.

Recruiting

Neoadjuvant Interstitial Brachytherapy Using Diffusing Alpha Emitters Radiation Therapy in Men With Prostate Cancer

Prostate Adenocarcinoma

Israel
Alpha Tau Medical LTD.

Completed

Alpha Radiation Emitters Device for the Treatment of Squamous Cell Carcinoma (DaRT)

Squamous Cell Carcinoma

Israel
Alpha Tau Medical LTD.

Recruiting

A Study of Diffusing Alpha Radiation Therapy for Patients With Breast Carcinoma in Frail or Elderly Patients.

Breast Cancer | Breast Carcinoma | Recurrent Breast Cancer

Israel
CCTU- Cancer Theme
Alpha Tau Medical LTD.

Recruiting

A Safety and Efficacy Study of Intra-tumoural Diffusing Alpha Radiation Emitters for the Treatment of Vulva Cancer (DaRT-V)

Vulvar Squamous Cell Carcinoma | Vulva Cancer, Recurrent | Vulva Cancer

United Kingdom
Alpha Tau Medical LTD.

Recruiting

Alpha Radiation Emitters Device for the Treatment of of Malignant Cutaneous Tumors

Skin Cancer | Cutaneous Tumor | Cutaneous Metastasis

France
Alpha Tau Medical LTD.

Completed

Feasibility Trial of Diffusing Alpha-emitter Radiation Therapy (DaRT) for Malignant Skin & Superficial Soft Tissue Tumors

Malignant Skin Tumor | Soft Tissue Tumor, Malignant

United States
Alpha Tau Medical LTD.

Not yet recruiting

Alpha Radiation Emitters Device for the Treatment of Pancreatic Cancer Emitters for the Treatment of Locally Advanced Pancreatic Cancer

Pancreatic Cancer | Pancreatic Adenocarcinoma | Unresectable Pancreatic Cancer
Hekabio

Completed

Radiation Therapy (HB-001) by Alpha-particle Sources for Recurrent Malignant Solid Tumors in Japan

Breast Cancer | Head and Neck Cancer

Japan
Alpha Tau Medical LTD.

Recruiting

Alpha Radiation Emitters Device for the Treatment of Advanced Pancreatic Cancer

Pancreatic Cancer | Pancreatic Adenocarcinoma | Metastatic Pancreatic Cancer | Unresectable Pancreatic Cancer

Canada
Alpha Tau Medical LTD.

Recruiting

A Feasibility and Safety Study of Intratumoral Diffusing Alpha Radiation Emitters for the Treatment of Advanced Pancreatic Cancer

Pancreatic Cancer | Pancreatic Adenocarcinoma | Metastatic Pancreatic Cancer | Unresectable Pancreatic Cancer

Israel
Alpha Tau Medical LTD.

Recruiting

Alpha Radiation Emitters Device for the Treatment of Liver Metastases (DaRT)

Liver Metastases

Canada
Alpha Tau Medical LTD.

Recruiting

A Safety and Efficacy Study for Combinational Treatment of DaRT and Check Point Inhibitor for Recurrent Unresectable or mHNSCC

Skin Cancer | Head and Neck Squamous Cell Carcinoma | Metastatic Head-and-neck Squamous-cell Carcinoma

Israel
Peking Union Medical College Hospital

Not yet recruiting

Online Adaptive Radiation Therapy for Rectal Cancer

Rectal Cancer
Institute of Cancer Research, United Kingdom

Unknown

3-Dimensional Conformal Radiation Therapy in Treating Patients With Bladder Cancer Who Have Undergone Transurethral Resection of the Bladder

Bladder Cancer

United Kingdom
Azimuth Therapy Ltd.

Unknown

Evaluating the Adequacy of Giro-Couch to Support Prone Breast Boost Irradiation Using IMRT Technique With IGRT. (IN902)

Breast Cancer

Israel
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

A Pilot Trial of Image-Guided Adaptive Radiotherapy for Head and Neck Cancer

Head and Neck Cancer | Oropharyngeal Cancer

United States
University of Michigan Rogel Cancer Center

Completed

A Pilot Trial to Determine the Extent of Inter- and Intra-Treatment Organ Motion Using Active Breathing Control Device (ABC) in Patients With Pancreatic Cancer

Pancreatic Cancer

United States
Paolo Cassano
North Suffolk Mental Health Association; Mclean Hospital

Completed

Transcranial Laser Therapy for Major Depressive Disorder (ELATED)

Major Depressive Disorder

United States
Abramson Cancer Center of the University of Pennsylvania
National Cancer Institute (NCI)

Completed

MRI Mapping in Planning Radiation Therapy to the Base of Skull and Brain in Patients With Nonmetastatic Head and Neck Cancer

Head and Neck Cancer

United States
University of California, San Francisco
North American Gamma Knife Consortium

Withdrawn

Neurocognitive Outcomes In Patients Treated With Radiotherapy For Five Or More Brain Metastases (NAGKC 12-01)

Brain Metastases

United States
Columbia University
Varian Medical Systems

Recruiting

AVI Didactic Experience for Latinx Patient Treatment Adherence and Non-English Speaker Trial Enrollment Study in Rad Onc (ADELANTE)

Prostate Cancer | Breast Cancer Invasive

United States
Albert Einstein College of Medicine
National Cancer Institute (NCI)

Withdrawn

Voxel Based Diffusion Tensor Imaging in Predicting Response in Patients With Brain Metastases Undergoing Whole Brain Radiation Therapy or Stereotactic Radiosurgery

Unspecified Adult Solid Tumor, Protocol Specific | Tumors Metastatic to Brain

United States
Fox Chase Cancer Center
National Cancer Institute (NCI)

Terminated

Chemoradiation and Radiosurgery Boost in Treating Patients With Locally Advance Pancreatic Cancer That May or May Not be Removed by Surgery

Acinar Cell Adenocarcinoma of the Pancreas | Duct Cell Adenocarcinoma of the Pancreas | Stage III Pancreatic Cancer | Stage IIB Pancreatic Cancer

United States
NYU Langone Health

Terminated

Image Guided Therapy in the Treatment of Gliomas

Glioma

United States
H. Lee Moffitt Cancer Center and Research Institute
Genentech, Inc.

Recruiting

Radiation Therapy Followed by Intrathecal Trastuzumab/Pertuzumab in HER2+ Breast Leptomeningeal Disease

HER2-positive Breast Cancer | Leptomeningeal Disease | Leptomeningeal Metastasis

United States
Icahn School of Medicine at Mount Sinai

Active, not recruiting

Rectal Spacer Hydrogel Before Radiation Therapy in Reducing Radiation Dose to the Rectum in Patients With Prostate Cancer

Prostate Cancer

United States
University of Maryland, Baltimore
Eli Lilly and Company

Completed

Low Dose Upper Abdominal Radiation Therapy (LD-UART) + Gemcitabine in Patients With Advanced, Unresectable Pancreatic Cancer (PC) (GCC0319)

Gastrointestinal Neoplasms | Ovarian Neoplasms

Canada, United States
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)

Completed

Post-Operative Adjuvant Radiotherapy With Concurrent Interferon-Alfa

Melanoma (Skin)

United States
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)

Completed

Interferon Alfa-2b With or Without Radiation Therapy in Treating Patients With Melanoma That Has Metastasized to Lymph Nodes in the Neck, Under the Arm, or in the Groin

Melanoma (Skin)

United States
University of Miami

Recruiting

SMART TNT for the Conservative Management of Locally Advanced Rectal Cancer (SMART TNT)

Locally Advanced Rectal Cancer

United States
Sidney Kimmel Cancer Center at Thomas Jefferson...
NovoCure Ltd.

Completed

Temozolomide, Radiation Therapy, and Tumor Treating Fields Therapy in Treating Participants With Glioblastoma

Glioblastoma

United States
IRCCS Policlinico S. Matteo

Completed

Clinical Results of Odyliresin (Iresine Celosia) in Symptomatic Benign Prostatic Hyperplasia (Odyliresin)

Benign Prostatic Hyperplasia | Benign Prostatic Hypertrophy With Outflow Obstruction

Italy
Fox Chase Cancer Center
National Cancer Institute (NCI)

Completed

Cisplatin, Interferon Alfa, Surgery, and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma

Malignant Mesothelioma

United States
Masonic Cancer Center, University of Minnesota

Terminated

Cyclophosphamide and Filgrastim Followed By SCT in Patients With Chronic or Accelerated Phase Myelogenous Leukemia

Leukemia

United States
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma

Adult Rhabdomyosarcoma | Embryonal Childhood Rhabdomyosarcoma | Embryonal-botryoid Childhood Rhabdomyosarcoma | Previously Untreated Childhood Rhabdomyosarcoma

United States, Canada, Australia, New Zealand, Puerto Rico, Switzerland
Children's Oncology Group
National Cancer Institute (NCI)

Active, not recruiting

Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor

Stage I Kidney Wilms Tumor | Stage II Kidney Wilms Tumor | Stage III Kidney Wilms Tumor | Stage IV Kidney Wilms Tumor | Adult Kidney Wilms Tumor | Beckwith-Wiedemann Syndrome | Childhood Kidney Wilms Tumor | Diffuse Hyperplastic Perilobar Nephroblastomatosis | Rhabdoid Tumor of the Kidney | Stage V Kidney...

United States, Canada, Australia, New Zealand, Puerto Rico, Israel
National Cancer Institute (NCI)
NRG Oncology

Active, not recruiting

Testing the Use of the Immunotherapy Drugs Ipilimumab and Nivolumab Plus Radiation Therapy Compared to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Unmethylated Glioblastoma

Gliosarcoma | MGMT-Unmethylated Glioblastoma

United States
National Cancer Institute (NCI)

Completed

flt3L With or Without Vaccine Therapy in Treating Patients With Metastatic Melanoma or Renal Cell Cancer

Recurrent Melanoma | Stage IV Melanoma | Stage IV Renal Cell Cancer | Recurrent Renal Cell Cancer

United States
NRG Oncology
National Cancer Institute (NCI)

Withdrawn

Testing the Addition of an Anti-cancer Viral Gene Therapy, Toca 511/Toca FC, to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed Glioblastoma

Glioblastoma | Anaplastic Astrocytoma | Oligodendroglioma | Supratentorial Glioblastoma
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Adjuvant Chemoradiotherapy and Interferon Alfa in Treating Patients With Resected Pancreatic Cancer

Pancreatic Cancer

United States
McGill University Health Centre/Research Institute...
ASGE

Completed

TC-325 (HEMOSPRAY™) VS. CURRENT STANDARD OF CARE IN MANAGING MALIGNANT GASTROINTESTINAL BLEEDING: A PILOT STUDY TO INFORM A RANDOMIZED CONTROLLED TRIAL.

MALIGNANT GASTROINTESTINAL BLEEDING

Canada

Search clinical trials for: Device: Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Croatia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations